{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:06:42Z","timestamp":1793452002584,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","award":["ID WS1948310"],"award-info":[{"award-number":["ID WS1948310"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sleep disturbances, fatigue, and anxiety\/depression in psoriatic arthritis (PsA) may be influenced by skin and musculoskeletal manifestations. All of these in turn affect the psychosocial impact of disease. The objective was to explore the occurrence of sleep disturbances, fatigue, and anxiety\/depression in psoriatic arthritis (PsA) patients, and their correlates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A broad data collection was performed in 137 Norwegian PsA outpatient clinic patients including demographics, disease activity measures for both skin and musculoskeletal involvement, and patient-reported outcome measures. Sleep disturbances and fatigue were defined present if the numeric rating scale (0\u201310) score was \u2265\u20095. Anxiety\/depression was assessed using a questionnaire (1\u20133; 1 defined as no anxiety\/depression). Descriptive statistics was applied, and associations were explored using univariate and adjusted linear regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age was 52.3\u2009years, PsA disease duration 8.8\u2009years; 49.6% were men and 54.8% were currently employed\/working. The prevalence of sleep disturbances was 38.0%, fatigue 44.5%, and anxiety\/depression 38.0%. In adjusted analysis, pain, fatigue, and higher mHAQ were associated with sleep disturbances. Sleep disturbances, pain, and anxiety\/depression were associated with fatigue, whereas only fatigue was associated with anxiety\/depression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The prevalence of sleep disturbances, fatigue, and anxiety\/depression was frequently reported by PsA patients. No measures reflecting skin involvement or objective measures of musculoskeletal involvement were independently associated with sleep disturbances, fatigue, or anxiety\/depression. Our data suggest that patients\u2019 perceptions of musculoskeletal involvement (pain or mHAQ) play an important role causing sleep disturbances and fatigue, whereas fatigue in PsA patients is strongly associated with anxiety\/depression.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-020-02294-w","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T04:12:03Z","timestamp":1598415123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Psoriatic arthritis: exploring the occurrence of sleep disturbances, fatigue, and depression and their correlates"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-5191","authenticated-orcid":false,"given":"Glenn","family":"Haugeberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"2294_CR1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370.","journal-title":"N Engl J Med"},{"key":"2294_CR2","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1007\/s11136-016-1321-7","volume":"25","author":"M Obradors","year":"2016","unstructured":"Obradors M, Blanch C, Comellas M, Figueras M, Lizan L. Health-related quality of life in patients with psoriasis: a systematic review of the European literature. Qual Life Res. 2016;25:2739\u201354.","journal-title":"Qual Life Res"},{"key":"2294_CR3","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/annrheumdis-2018-213286","volume":"77","author":"B Michelsen","year":"2018","unstructured":"Michelsen B, Uhlig T, Sexton J, van der Heijde D, Hammer HB, Kristianslund EK, et al. Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis. 2018;77:1290\u20134.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR4","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2011-200387","volume":"71","author":"V Strand","year":"2012","unstructured":"Strand V, Sharp V, Koenig AS, Park G, Shi Y, Wang B, et al. Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment. Ann Rheum Dis. 2012;71:1143\u201350.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR5","first-page":"563","volume":"8","author":"B Truong","year":"2015","unstructured":"Truong B, Rich-Garg N, Ehst BD, Deodhar AA, Ku JH, Vakil-Gilani K, et al. Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis. Clin Cosmet Investig Dermatol. 2015;8:563\u20139.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"2294_CR6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/annrheumdis-2018-215003","volume":"78","author":"A Kavanaugh","year":"2019","unstructured":"Kavanaugh A, Gottlieb A, Morita A, Merola JF, Lin CY, Birt J, et al. The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis. 2019;78:1215\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","volume":"47","author":"ME Husni","year":"2017","unstructured":"Husni ME, Merola JF, Davin S. The psychosocial burden of psoriatic arthritis. Semin Arthritis Rheum. 2017;47:351\u201360.","journal-title":"Semin Arthritis Rheum"},{"key":"2294_CR8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","volume":"41","author":"ME Husni","year":"2015","unstructured":"Husni ME. Comorbidities in psoriatic arthritis. Rheum Dis Clin N Am. 2015;41:677\u201398.","journal-title":"Rheum Dis Clin N Am"},{"key":"2294_CR9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/annrheumdis-2016-210242","volume":"76","author":"AM Orbai","year":"2017","unstructured":"Orbai AM, de Wit M, Mease P, Shea JA, Gossec L, Leung YY, et al. International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials. Ann Rheum Dis. 2017;76:673\u201380.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR10","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3899\/jrheum.160973","volume":"44","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Diamantopoulos AP, Hoiberg HK, Soldal DM, Kavanaugh A, Haugeberg G. Need for improvement in current treatment of psoriatic arthritis: study of an outpatient clinic population. J Rheumatol. 2017;44:431\u20136.","journal-title":"J Rheumatol"},{"key":"2294_CR12","doi-asserted-by":"crossref","unstructured":"EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199\u2013208.","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"2294_CR13","doi-asserted-by":"publisher","unstructured":"Haugeberg G, Michelsen B, Kavanaugh A. Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. 2020;6(1):e001223. https:\/\/doi.org\/10.1136\/rmdopen-2020-001223.","DOI":"10.1136\/rmdopen-2020-001223"},{"key":"2294_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ijd.12649","volume":"55","author":"I Balta","year":"2016","unstructured":"Balta I, Karadag AS, Selek S, Onder S, Kanbay A, Burakgazi-Yilmaz H. General psychiatric symptoms, quality of sleep, and coping strategies in patients with psoriasis vulgaris. Int J Dermatol. 2016;55:60\u20134.","journal-title":"Int J Dermatol"},{"key":"2294_CR15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11325-019-01820-8","volume":"23","author":"H Sacmaci","year":"2019","unstructured":"Sacmaci H, Gurel G. Sleep disorders in patients with psoriasis: a cross-sectional study using non-polysomnographical methods. Sleep Breath. 2019;23:893\u20138.","journal-title":"Sleep Breath"},{"key":"2294_CR16","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bjd.16702","volume":"179","author":"P Jensen","year":"2018","unstructured":"Jensen P, Zachariae C, Skov L, Zachariae R. Sleep disturbance in psoriasis: a case-controlled study. Br J Dermatol. 2018;179:1376\u201384.","journal-title":"Br J Dermatol"},{"key":"2294_CR17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/bjd.12000","volume":"167","author":"BE Strober","year":"2012","unstructured":"Strober BE, Sobell JM, Duffin KC, Bao Y, Guerin A, Yang H, et al. Sleep quality and other patient-reported outcomes improve after patients with psoriasis with suboptimal response to other systemic therapies are switched to adalimumab: results from PROGRESS, an open-label phase IIIb trial. Br J Dermatol. 2012;167:1374\u201381.","journal-title":"Br J Dermatol"},{"key":"2294_CR18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/1756-185X.12505","volume":"20","author":"O Gezer","year":"2017","unstructured":"Gezer O, Batmaz I, Sariyildiz MA, Sula B, Ucmak D, Bozkurt M, et al. Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis. 2017;20:1212\u20138.","journal-title":"Int J Rheum Dis"},{"key":"2294_CR19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jaad.2008.10.059","volume":"60","author":"K Callis Duffin","year":"2009","unstructured":"Callis Duffin K, Wong B, Horn EJ, Krueger GG. Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasis. J Am Acad Dermatol. 2009;60:604\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"2294_CR20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3899\/jrheum.161330","volume":"44","author":"ITY Wong","year":"2017","unstructured":"Wong ITY, Chandran V, Li S, Gladman DD. Sleep disturbance in psoriatic disease: prevalence and associated factors. J Rheumatol. 2017;44:1369\u201374.","journal-title":"J Rheumatol"},{"key":"2294_CR21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00403-019-01906-z","volume":"311","author":"A Duvetorp","year":"2019","unstructured":"Duvetorp A, Ostergaard M, Skov L, Seifert O, Tveit KS, Danielsen K, et al. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Arch Dermatol Res. 2019;311:351\u201360.","journal-title":"Arch Dermatol Res"},{"key":"2294_CR22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jdv.12207","volume":"28","author":"D Thaci","year":"2014","unstructured":"Thaci D, Galimberti R, Amaya-Guerra M, Rosenbach T, Robertson D, Pedersen R, et al. Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate-to-severe psoriasis: results from the pristine trial. J Eur Acad Dermatol Venereol. 2014;28:900\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2294_CR23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5114\/reum.2018.79501","volume":"56","author":"M Krajewska-Wlodarczyk","year":"2018","unstructured":"Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W. Sleep disorders in patients with psoriatic arthritis and psoriasis. Reumatologia. 2018;56:301\u20136.","journal-title":"Reumatologia"},{"key":"2294_CR24","doi-asserted-by":"publisher","unstructured":"Haugeberg G LNT, Kavanaugh A, Stoklund Nilsen R, Malm Gulati A, Hoff M. The physical and psychosocial burden of psoriatic arthritis: longitudinal data from the population based HUNT study, Norway. Arthritis Care Res. 2020. https:\/\/doi.org\/10.1002\/acr.24412.","DOI":"10.1002\/acr.24412"},{"key":"2294_CR25","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jpain.2013.08.007","volume":"14","author":"PH Finan","year":"2013","unstructured":"Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14:1539\u201352.","journal-title":"J Pain"},{"key":"2294_CR26","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.jid.2017.07.822","volume":"137","author":"I Snekvik","year":"2017","unstructured":"Snekvik I, Smith CH, Nilsen TIL, Langan SM, Modalsli EH, Romundstad PR, et al. Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study. J Invest Dermatol. 2017;137:2484\u201390.","journal-title":"J Invest Dermatol"},{"key":"2294_CR27","doi-asserted-by":"publisher","unstructured":"Thomsen RS, Nilsen TI, Haugeberg G, Gulati AM, Kavanaugh A, Hoff M. Adiposity and physical activity as risk factors for developing psoriatic arthritis. Longitudinal data from the HUNT study. Arthritis Care Res (Hoboken). 2019. https:\/\/doi.org\/10.1002\/acr.24121. Online ahead of print. PMID: 31811695.","DOI":"10.1002\/acr.24121"},{"key":"2294_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.smrv.2015.09.003","volume":"29","author":"MA Gupta","year":"2016","unstructured":"Gupta MA, Simpson FC, Gupta AK. Psoriasis and sleep disorders: a systematic review. Sleep Med Rev. 2016;29:63\u201375.","journal-title":"Sleep Med Rev"},{"key":"2294_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000152","volume":"27","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Schwartzman S, Husni ME. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol. 2015;27:118\u201326.","journal-title":"Curr Opin Rheumatol"},{"key":"2294_CR30","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMcp1816152","volume":"380","author":"SC Veasey","year":"2019","unstructured":"Veasey SC, Rosen IM. Obstructive sleep apnea in adults. N Engl J Med. 2019;380:1442\u20139.","journal-title":"N Engl J Med"},{"key":"2294_CR31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3389\/fimmu.2019.01827","volume":"10","author":"MR Zielinski","year":"2019","unstructured":"Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;10:1827.","journal-title":"Front Immunol"},{"key":"2294_CR32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40257-019-00434-w","volume":"20","author":"IM Skoie","year":"2019","unstructured":"Skoie IM, Dalen I, Omdal R. Effect of biological treatment on fatigue in psoriasis: a systematic review and meta-analysis. Am J Clin Dermatol. 2019;20:493\u2013502.","journal-title":"Am J Clin Dermatol"},{"key":"2294_CR33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbspin.2018.01.011","volume":"85","author":"T Reygaerts","year":"2018","unstructured":"Reygaerts T, Mitrovic S, Fautrel B, Gossec L. Effect of biologics on fatigue in psoriatic arthritis: a systematic literature review with meta-analysis. Joint Bone Spine. 2018;85:405\u201310.","journal-title":"Joint Bone Spine"},{"key":"2294_CR34","doi-asserted-by":"crossref","first-page":"101434","DOI":"10.1016\/j.berh.2019.101434","volume":"33","author":"T Boeselt","year":"2019","unstructured":"Boeselt T, Koczulla R, Nell C, Beutel B, Guenter K, Cassel W, et al. Sleep and rheumatic diseases. Best Pract Res Clin Rheumatol. 2019;33:101434.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2294_CR35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/acr.23614","volume":"71","author":"RS Thomsen","year":"2019","unstructured":"Thomsen RS, Nilsen TIL, Haugeberg G, Bye A, Kavanaugh A, Hoff M. Impact of high-intensity interval training on disease activity and disease in patients with psoriatic arthritis: a randomized controlled trial. Arthritis Care Res (Hoboken). 2019;71:530\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2294_CR36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.15375","volume":"177","author":"IM Skoie","year":"2017","unstructured":"Skoie IM, Dalen I, Ternowitz T, Jonsson G, Kvivik I, Norheim K, et al. Fatigue in psoriasis: a controlled study. Br J Dermatol. 2017;177:505\u201312.","journal-title":"Br J Dermatol"},{"key":"2294_CR37","doi-asserted-by":"crossref","first-page":"e0123582","DOI":"10.1371\/journal.pone.0123582","volume":"10","author":"B Michelsen","year":"2015","unstructured":"Michelsen B, Fiane R, Diamantopoulos AP, Soldal DM, Hansen IJ, Sokka T, et al. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. PLoS One. 2015;10:e0123582.","journal-title":"PLoS One"},{"key":"2294_CR38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jbspin.2015.07.017","volume":"83","author":"T Gudu","year":"2016","unstructured":"Gudu T, Etcheto A, de Wit M, Heiberg T, Maccarone M, Balanescu A, et al. Fatigue in psoriatic arthritis - a cross-sectional study of 246 patients from 13 countries. Joint Bone Spine. 2016;83:439\u201343.","journal-title":"Joint Bone Spine"},{"key":"2294_CR39","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/ard.2008.098202","volume":"68","author":"JA Husted","year":"2009","unstructured":"Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD. Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis. 2009;68:1553\u20138.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/1744666X.2018.1468252","volume":"14","author":"T Gudu","year":"2018","unstructured":"Gudu T, Gossec L. Quality of life in psoriatic arthritis. Expert Rev Clin Immunol. 2018;14:405\u201317.","journal-title":"Expert Rev Clin Immunol"},{"key":"2294_CR41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3899\/jrheum.181412","volume":"47","author":"M Skougaard","year":"2020","unstructured":"Skougaard M, J\u00f8rgensen TS, Rifbjerg-Madsen S, Coates LC, Egeberg A, Amris K, et al. Relationship between fatigue and inflammation, disease duration, and chronic pain in psoriatic arthritis: an observational DANBIO registry study. J Rheumatol. 2020;47:548\u201352.","journal-title":"J Rheumatol"},{"key":"2294_CR42","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3899\/jrheum.100179","volume":"37","author":"JA Husted","year":"2010","unstructured":"Husted JA, Tom BD, Farewell VT, Gladman DD. Longitudinal analysis of fatigue in psoriatic arthritis. J Rheumatol. 2010;37:1878\u201384.","journal-title":"J Rheumatol"},{"key":"2294_CR43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-019-04734-8","volume":"39","author":"SS Zhao","year":"2020","unstructured":"Zhao SS, Miller N, Harrison N, Duffield SJ, Dey M, Goodson NJ. Systematic review of mental health comorbidities in psoriatic arthritis. Clin Rheumatol. 2020;39:217\u201325.","journal-title":"Clin Rheumatol"},{"key":"2294_CR44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1756-185X.13553","volume":"22","author":"N Kamalaraj","year":"2019","unstructured":"Kamalaraj N, El-Haddad C, Hay P, Pile K. Systematic review of depression and anxiety in psoriatic arthritis. Int J Rheum Dis. 2019;22:967\u201373.","journal-title":"Int J Rheum Dis"},{"key":"2294_CR45","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","volume":"76","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis. 2017;76:1906\u201310.","journal-title":"Ann Rheum Dis"},{"key":"2294_CR46","doi-asserted-by":"crossref","unstructured":"Iannone F, Nivuori M, Fornaro M, Venerito V, Cacciapaglia F, Lopalco G. Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis. Rheumatology (Oxford). 2020;59:1599\u20131606.","DOI":"10.1093\/rheumatology\/kez505"},{"key":"2294_CR47","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/jdv.12909","volume":"29","author":"P Fleming","year":"2015","unstructured":"Fleming P, Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, et al. Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2015;29:1063\u201370.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2294_CR48","doi-asserted-by":"crossref","first-page":"e3816","DOI":"10.1097\/MD.0000000000003816","volume":"95","author":"CY Wu","year":"2016","unstructured":"Wu CY, Chang YT, Juan CK, Shen JL, Lin YP, Shieh JJ, et al. Depression and insomnia in patients with psoriasis and psoriatic arthritis taking tumor necrosis factor antagonists. Medicine (Baltimore). 2016;95:e3816.","journal-title":"Medicine (Baltimore)"},{"key":"2294_CR49","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/acr.23000","volume":"68","author":"P Rahman","year":"2016","unstructured":"Rahman P, Puig L, Gottlieb AB, Kavanaugh A, McInnes IB, Ritchlin C, et al. Ustekinumab treatment and improvement of physical function and health-related quality of life in patients with psoriatic arthritis. Arthritis Care Res (Hoboken). 2016;68:1812\u201322.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02294-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02294-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:52:44Z","timestamp":1696582364000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02294-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02294-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Regional Committee for Medical Research Ethics in South-Eastern Norway (REK number: 2012\/101). All participating patients gave their written consent. The study was conducted in accordance with the Declaration of Helsinki, and all participants signed informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}